He J, Aljohani A, Mustafa S, Shokri A, Khalsaraei M, Mukalazi H
Sci Rep. 2024; 14(1):17413.
PMID: 39075079
PMC: 11286927.
DOI: 10.1038/s41598-024-66503-1.
Periferakis A, Periferakis K, Badarau I, Petran E, Popa D, Caruntu A
Int J Mol Sci. 2022; 23(23).
PMID: 36499380
PMC: 9740324.
DOI: 10.3390/ijms232315054.
Emeribe A, Dangana A, Isa H, Onoja S, Otu T, Ibrahim Y
Biomedicine (Taipei). 2022; 12(1):1-13.
PMID: 35836914
PMC: 9236713.
DOI: 10.37796/2211-8039.1237.
Shah M, Hwang J, Choi L, Lindblade K, Kachur S, Desai M
Cochrane Database Syst Rev. 2021; 9:CD008846.
PMID: 34585740
PMC: 8479726.
DOI: 10.1002/14651858.CD008846.pub3.
Esu E, Oringanje C, Meremikwu M
Cochrane Database Syst Rev. 2021; 7:CD011525.
PMID: 34273901
PMC: 8406727.
DOI: 10.1002/14651858.CD011525.pub3.
To screen or not to screen: an interactive framework for comparing costs of mass malaria treatment interventions.
Millar J, Toh K, Valle D
BMC Med. 2020; 18(1):149.
PMID: 32552743
PMC: 7304173.
DOI: 10.1186/s12916-020-01609-7.
Prevalence of chloroquine and antifolate drug resistance alleles in clinical isolates from three areas in Ghana.
Abugri J, Ansah F, Asante K, Opoku C, Amenga-Etego L, Awandare G
AAS Open Res. 2020; 1:1.
PMID: 32382694
PMC: 7185243.
DOI: 10.12688/aasopenres.12825.2.
Resurgence of malaria infection after mass treatment: a simulation study.
Smith T, Pemberton-Ross P, Penny M, Chitnis N
Malar J. 2019; 18(1):409.
PMID: 31805947
PMC: 6896478.
DOI: 10.1186/s12936-019-3019-0.
Intermittent preventive treatment for malaria in infants.
Esu E, Oringanje C, Meremikwu M
Cochrane Database Syst Rev. 2019; 12:CD011525.
PMID: 31792925
PMC: 6887842.
DOI: 10.1002/14651858.CD011525.pub2.
Comparative effectiveness of malaria prevention measures: a systematic review and network meta-analysis.
Wangdi K, Furuya-Kanamori L, Clark J, Barendregt J, Gatton M, Banwell C
Parasit Vectors. 2018; 11(1):210.
PMID: 29587882
PMC: 5869791.
DOI: 10.1186/s13071-018-2783-y.
Cost-Benefit Analysis of Malaria Chemoprophylaxis and Early Diagnosis for Korean Soldiers in Malaria Risk Regions.
Kim H, Kang G, Lee S, Yoon C, Kim M
J Korean Med Sci. 2018; 33(10):e59.
PMID: 29495139
PMC: 5832939.
DOI: 10.3346/jkms.2018.33.e59.
Perceptions and practices for preventing malaria in pregnancy in a peri-urban setting in south-western Uganda.
Mbonye A, Mohamud S, Bagonza J
Malar J. 2016; 15:211.
PMID: 27075575
PMC: 4831145.
DOI: 10.1186/s12936-016-1246-1.
Large contractors in Africa: conundrums with malaria chemoprophylaxis.
Braack L
Malar J. 2016; 15:207.
PMID: 27071552
PMC: 4830036.
DOI: 10.1186/s12936-016-1265-y.
Prevention of Malaria Resurgence in Greece through the Association of Mass Drug Administration (MDA) to Immigrants from Malaria-Endemic Regions and Standard Control Measures.
Tseroni M, Baka A, Kapizioni C, Snounou G, Tsiodras S, Charvalakou M
PLoS Negl Trop Dis. 2015; 9(11):e0004215.
PMID: 26583650
PMC: 4652894.
DOI: 10.1371/journal.pntd.0004215.
Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
Gerardin J, Eckhoff P, Wenger E
BMC Infect Dis. 2015; 15:144.
PMID: 25887935
PMC: 4376519.
DOI: 10.1186/s12879-015-0887-y.
The relationship between Plasmodium infection, anaemia and nutritional status in asymptomatic children aged under five years living in stable transmission zones in Kinshasa, Democratic Republic of Congo.
Maketa V, Muhindo Mavoko H, Inocencio da Luz R, Zanga J, Lubiba J, Kalonji A
Malar J. 2015; 14:83.
PMID: 25880427
PMC: 4336722.
DOI: 10.1186/s12936-015-0595-5.
Iron, anemia and hepcidin in malaria.
Spottiswoode N, Duffy P, Drakesmith H
Front Pharmacol. 2014; 5:125.
PMID: 24910614
PMC: 4039013.
DOI: 10.3389/fphar.2014.00125.
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
Nankabirwa J, Wandera B, Amuge P, Kiwanuka N, Dorsey G, Rosenthal P
Clin Infect Dis. 2014; 58(10):1404-12.
PMID: 24621953
PMC: 4001293.
DOI: 10.1093/cid/ciu150.
Mass drug administration for malaria.
Poirot E, Skarbinski J, Sinclair D, Kachur S, Slutsker L, Hwang J
Cochrane Database Syst Rev. 2013; (12):CD008846.
PMID: 24318836
PMC: 4468927.
DOI: 10.1002/14651858.CD008846.pub2.
Mass drug administration for the control and elimination of Plasmodium vivax malaria: an ecological study from Jiangsu province, China.
Hsiang M, Hwang J, Tao A, Liu Y, Bennett A, Shanks G
Malar J. 2013; 12:383.
PMID: 24175930
PMC: 3842644.
DOI: 10.1186/1475-2875-12-383.